Salvadori Daniel Gesua Sive 4
4 · ABBOTT LABORATORIES · Filed Jan 31, 2025
Insider Transaction Report
Form 4
Salvadori Daniel Gesua Sive
EVP AND GROUP PRESIDENT
Transactions
- Exercise/Conversion
Option (right to buy)
2025-01-30−23,771→ 0 totalExercise: $38.40From: 2019-02-19Exp: 2026-02-18→ Common Shares (23,771 underlying) - Sale
Common shares without par value
2025-01-30$128.50/sh−23,771$3,054,574→ 125,697 total - Exercise/Conversion
Common shares without par value
2025-01-30$38.40/sh+23,771$912,806→ 149,468 total
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.